These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Induction of pituitary sensitivity to interleukin-1: a new function for corticotropin-releasing hormone. Payne LC; Weigent DA; Blalock JE Biochem Biophys Res Commun; 1994 Jan; 198(2):480-4. PubMed ID: 8297358 [TBL] [Abstract][Full Text] [Related]
6. Stress-induced immune suppression: role of brain corticotropin releasing hormone and autonomic nervous system mechanisms. Irwin M Adv Neuroimmunol; 1994; 4(1):29-47. PubMed ID: 8049860 [No Abstract] [Full Text] [Related]
7. Hypothalamic releasing hormones mediating the effects of interleukin-1 on sleep. Payne LC; Obál F; Krueger JM J Cell Biochem; 1993 Dec; 53(4):309-13. PubMed ID: 8300748 [TBL] [Abstract][Full Text] [Related]
8. Regulation of B cell tolerance by macrophage-derived mediators: antagonistic effects of prostaglandin E2 and interleukin 1. Goldings EA J Immunol; 1986 Feb; 136(3):817-22. PubMed ID: 2416834 [TBL] [Abstract][Full Text] [Related]
9. Macrophage handling of a tolerogen and the role of IL 1 in tolerance induction in a helper T cell clone in vitro. Levich JD; Signorella AP; Wittenberg G; Weigle WO J Immunol; 1987 Jun; 138(11):3675-9. PubMed ID: 2438325 [TBL] [Abstract][Full Text] [Related]
10. Skewing the Th cell phenotype toward Th1 alters the maturation of tumor-infiltrating mononuclear phagocytes. Nonaka K; Saio M; Suwa T; Frey AB; Umemura N; Imai H; Ouyang GF; Osada S; Balazs M; Adany R; Kawaguchi Y; Yoshida K; Takami T J Leukoc Biol; 2008 Sep; 84(3):679-88. PubMed ID: 18566103 [TBL] [Abstract][Full Text] [Related]
11. Interleukin-18 displays effects opposite to those of interleukin-1 in the regulation of neuroendocrine stress axis. Tringali G; Pozzoli G; Vairano M; Mores N; Preziosi P; Navarra P J Neuroimmunol; 2005 Mar; 160(1-2):61-7. PubMed ID: 15710458 [TBL] [Abstract][Full Text] [Related]
12. Stress system activity, innate and T helper cytokines, and susceptibility to immune-related diseases. Calcagni E; Elenkov I Ann N Y Acad Sci; 2006 Jun; 1069():62-76. PubMed ID: 16855135 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological activity of N-terminal lipidated and/or fluorescently labeled conjugates of astressin as corticotropin releasing factor antagonists. Rijkers DT; den Hartog JA; Liskamp RM Bioorg Med Chem; 2004 Oct; 12(19):5099-106. PubMed ID: 15351393 [TBL] [Abstract][Full Text] [Related]
15. The role of IL-1 in the corticotropin-releasing factor and arginine- vasopressin-induced secretion of immunoreactive beta-endorphin by human peripheral blood mononuclear cells. Kavelaars A; Ballieux RE; Heijnen CJ J Immunol; 1989 Apr; 142(7):2338-42. PubMed ID: 2522482 [TBL] [Abstract][Full Text] [Related]
16. Intermittent but not continuous inescapable footshock stress affects immune responses and immunocyte beta-endorphin concentrations in the rat. Sacerdote P; Manfredi B; Bianchi M; Panerai AE Brain Behav Immun; 1994 Sep; 8(3):251-60. PubMed ID: 7865896 [TBL] [Abstract][Full Text] [Related]
17. Immunosuppressive phenotype of corticotropin-releasing factor transgenic mice is reversed by adrenalectomy. Boehme SA; Gaur A; Crowe PD; Liu XJ; Tamraz S; Wong T; Pahuja A; Ling N; Vale W; De Souza EB; Conlon PJ Cell Immunol; 1997 Mar; 176(2):103-12. PubMed ID: 9073382 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of corticotropin releasing factor (CRF)-induced adrenocorticotropin (ACTH) secretion in pituitary corticotropic cells by substance P. Melzig MF; Papsdorf G; Putscher I; Winkler A; Siems WE Pharmazie; 1998 Aug; 53(8):569-72. PubMed ID: 9741065 [TBL] [Abstract][Full Text] [Related]
19. Immunosuppression in murine malaria: suppressor role of macrophages and their products during acute and chronic Plasmodium berghei infection. Wangoo A; Ganguly NK; Mahajan RC APMIS; 1990 May; 98(5):407-14. PubMed ID: 2141476 [TBL] [Abstract][Full Text] [Related]
20. The role of corticotropin-releasing hormone in immune-mediated cutaneous inflammatory disease. O'Kane M; Murphy EP; Kirby B Exp Dermatol; 2006 Mar; 15(3):143-53. PubMed ID: 16480421 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]